Braydon A. Meyer - Publications

DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.

Journal: Clinical epigenetics

Published: September 19, 2025

Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling.

Journal: BMC genomics

Published: October 12, 2023

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.

Journal: The Journal of pathology

Published: July 25, 2023

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.

Journal: Nature structural & molecular biology

Published: December 13, 2022

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.

Journal: Clinical epigenetics

Published: September 24, 2021

DNA methylation profiling identifies epigenetic differences between early versus late stages of diabetic chronic kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 26, 2020

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry.

Journal: Journal of visualized experiments : JoVE

Published: July 10, 2018

DNA methylation at IL32 in juvenile idiopathic arthritis.

Journal: Scientific reports

Published: February 08, 2015